{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:40:57Z","timestamp":1792428057872,"version":"4.5.0"},"reference-count":160,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303741"],"award-info":[{"award-number":["82303741"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the National Key R&D Program of China","award":["2022YFC2704103"],"award-info":[{"award-number":["2022YFC2704103"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-026-02174-1","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T12:55:12Z","timestamp":1784724912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["New perspective on epigenetic modification and immunotherapy in endometrial cancer"],"prefix":"10.1186","volume":"18","author":[{"given":"Haoqian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanshan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"3","key":"2174_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012513.pub3","volume":"3","author":"H Agnew","year":"2023","unstructured":"Agnew H, Kitson S, Crosbie EJ. Interventions for weight reduction in obesity to improve survival in women with endometrial cancer. Cochrane Database Syst Rev. 2023;3(3):Cd012513. https:\/\/doi.org\/10.1002\/14651858.CD012513.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2174_CR2","first-page":"125","volume":"36","author":"MY Ahn","year":"2010","unstructured":"Ahn MY, Chung HY, Choi WS, Lee BM, Yoon S, Kim HS. Anti-tumor effect of apicidin on Ishikawa human endometrial cancer cells both in vitro and in vivo by blocking histone deacetylase 3 and 4. Int J Oncol. 2010;36(1):125\u201331.","journal-title":"Int J Oncol"},{"key":"2174_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cell.2013.06.018","volume":"154","author":"D Aran","year":"2013","unstructured":"Aran D, Hellman A. DNA Methylation of transcriptional enhancers and cancer predisposition. Cell. 2013;154:11\u20133. https:\/\/doi.org\/10.1016\/j.cell.2013.06.018.","journal-title":"Cell"},{"issue":"42","key":"2174_CR4","doi-asserted-by":"publisher","first-page":"5666","DOI":"10.1038\/s41388-018-0360-7","volume":"37","author":"M Bai","year":"2018","unstructured":"Bai M, Yang L, Liao H, Liang X, Xie B, Xiong J, et al. Metformin sensitizes endometrial cancer cells to chemotherapy through IDH1-induced Nrf2 expression via an epigenetic mechanism. Oncogene. 2018;37(42):5666\u201381. https:\/\/doi.org\/10.1038\/s41388-018-0360-7.","journal-title":"Oncogene"},{"key":"2174_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/738274","volume":"2012","author":"K Banno","year":"2012","unstructured":"Banno K, Kisu I, Yanokura M, Masuda K, Kobayashi Y, Ueki A, et al. Endometrial cancer and hypermethylation: regulation of DNA and MicroRNA by epigenetics. Biochem Res Int. 2012;2012:738274. https:\/\/doi.org\/10.1155\/2012\/738274.","journal-title":"Biochem Res Int"},{"key":"2174_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1117850","volume":"10","author":"JJ Barchi Jr.","year":"2023","unstructured":"Barchi JJ Jr., Strain CN. The effect of a methyl group on structure and function: Serine vs. threonine glycosylation and phosphorylation. Front Mol Biosci. 2023;10:1117850. https:\/\/doi.org\/10.3389\/fmolb.2023.1117850.","journal-title":"Front Mol Biosci"},{"key":"2174_CR7","doi-asserted-by":"publisher","first-page":"1101480","DOI":"10.3389\/fcell.2023.1101480","volume":"11","author":"K Bedelbaeva","year":"2023","unstructured":"Bedelbaeva K, Cameron B, Latella J, Aslanukov A, Gourevitch D, Davuluri R, et al. Epithelial-mesenchymal transition: an organizing principle of mammalian regeneration. Front Cell Dev Biol. 2023;11:1101480. https:\/\/doi.org\/10.3389\/fcell.2023.1101480.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"2174_CR8","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3892\/or.2020.7648","volume":"44","author":"MJ Besso","year":"2020","unstructured":"Besso MJ, Montivero L, Lacunza E, Argibay MC, Abba M, Furlong LI, et al. Identification of early stage recurrence endometrial cancer biomarkers using bioinformatics tools. Oncol Rep. 2020;44(3):873\u201386. https:\/\/doi.org\/10.3892\/or.2020.7648.","journal-title":"Oncol Rep"},{"key":"2174_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14010066","author":"E Borcoman","year":"2021","unstructured":"Borcoman E, Kamal M, Marret G, Dupain C, Castel-Ajgal Z, Le Tourneau C. HDAC inhibition to prime immune checkpoint inhibitors. Cancers. 2021. https:\/\/doi.org\/10.3390\/cancers14010066.","journal-title":"Cancers"},{"key":"2174_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae1303","author":"G Boysen","year":"2025","unstructured":"Boysen G, Alexandrov LB, Rahbari R, Nookaew I, Ussery D, Chao MR, et al. Investigating the origins of the mutational signatures in cancer. Nucleic Acids Res. 2025. https:\/\/doi.org\/10.1093\/nar\/gkae1303.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"2174_CR11","doi-asserted-by":"publisher","first-page":"e00772","DOI":"10.1002\/mgg3.772","volume":"7","author":"E Bussaglia","year":"2019","unstructured":"Bussaglia E, Ant\u00f3n R, Nomded\u00e9u JF, Fuentes-Prior P. TET2 missense variants in human neoplasia. A proposal of structural and functional classification. Mol Genet Genomic Med. 2019;7(7):e00772. https:\/\/doi.org\/10.1002\/mgg3.772.","journal-title":"Mol Genet Genomic Med"},{"issue":"9","key":"2174_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41389-020-00265-z","volume":"9","author":"G Chen","year":"2020","unstructured":"Chen G, Liu B, Yin S, Li S, Guo Y, Wang M, et al. Hypoxia induces an endometrial cancer stem-like cell phenotype via HIF-dependent demethylation of SOX2 mRNA. Oncogenesis. 2020;9(9):81. https:\/\/doi.org\/10.1038\/s41389-020-00265-z.","journal-title":"Oncogenesis"},{"key":"2174_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194718","author":"G Chen","year":"2022","unstructured":"Chen G, Yan Q, Liu L, Wen X, Zeng H, Yin S. Histone deacetylase 3 governs \u03b2-estradiol-ER\u03b1-Involved endometrial tumorigenesis via inhibition of STING transcription. Cancers. 2022. https:\/\/doi.org\/10.3390\/cancers14194718.","journal-title":"Cancers"},{"issue":"8","key":"2174_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2024.100532","volume":"37","author":"H Chen","year":"2024","unstructured":"Chen H, Molberg K, Carrick K, Niu S, Rivera Colon G, Gwin K, et al. Expression and prognostic significance of LAG-3, TIGIT, VISTA, and IDO1 in endometrial serous carcinoma. Mod Pathol. 2024;37(8):100532. https:\/\/doi.org\/10.1016\/j.modpat.2024.100532.","journal-title":"Mod Pathol"},{"issue":"4","key":"2174_CR15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3233\/cbm-160419","volume":"19","author":"X Chen","year":"2017","unstructured":"Chen X, Lai X, Wu C, Tian Q, Lei T, Pan J, et al. Decreased SIRT4 protein levels in endometrioid adenocarcinoma tissues are associated with advanced AJCC stage. Cancer Biomark. 2017;19(4):419\u201324. https:\/\/doi.org\/10.3233\/cbm-160419.","journal-title":"Cancer Biomark"},{"issue":"17","key":"2174_CR16","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1007\/s00018-014-1580-9","volume":"71","author":"Y Chu","year":"2014","unstructured":"Chu Y, Wang Y, Zhang G, Chen H, Dowdy SC, Xiong Y, et al. Chromatin composition alterations and the critical role of MeCP2 for epigenetic silencing of progesterone receptor-B gene in endometrial cancers. Cell Mol Life Sci. 2014;71(17):3393\u2013408. https:\/\/doi.org\/10.1007\/s00018-014-1580-9.","journal-title":"Cell Mol Life Sci"},{"key":"2174_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413239","author":"P Ciesielski","year":"2021","unstructured":"Ciesielski P, J\u00f3\u017awiak P, Forma E, Krze\u015blak A. TET3- and OGT-dependent expression of genes involved in epithelial-mesenchymal transition in endometrial cancer. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222413239.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2174_CR18","doi-asserted-by":"publisher","first-page":"101042831769501","DOI":"10.1177\/1010428317695017","volume":"39","author":"P Ciesielski","year":"2017","unstructured":"Ciesielski P, J\u00f3\u017awiak P, W\u00f3jcik-Krowiranda K, Forma E, Cwonda \u0141, Szczepaniec S, et al. Differential expression of ten-eleven translocation genes in endometrial cancers. Tumour Biol. 2017;39(3):1010428317695017. https:\/\/doi.org\/10.1177\/1010428317695017.","journal-title":"Tumour Biol"},{"issue":"9","key":"2174_CR19","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/s1470-2045(24)00334-6","volume":"25","author":"N Colombo","year":"2024","unstructured":"Colombo N, Biagioli E, Harano K, Galli F, Hudson E, Antill Y, et al. Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2024;25(9):1135\u201346. https:\/\/doi.org\/10.1016\/s1470-2045(24)00334-6.","journal-title":"Lancet Oncol"},{"issue":"7441","key":"2174_CR20","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nature11925","volume":"495","author":"Y Costa","year":"2013","unstructured":"Costa Y, Ding J, Theunissen TW, Faiola F, Hore TA, Shliaha PV, et al. NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. Nature. 2013;495(7441):370\u20134. https:\/\/doi.org\/10.1038\/nature11925.","journal-title":"Nature"},{"issue":"4","key":"2174_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.108018","volume":"50","author":"I Cuccu","year":"2024","unstructured":"Cuccu I, Raspagliesi F, Malzoni M, Vizza E, Papadia A, Di Donato V, et al. Sentinel node mapping in high-intermediate and high-risk endometrial cancer: analysis of 5-year oncologic outcomes. Eur J Surg Oncol. 2024;50(4):108018. https:\/\/doi.org\/10.1016\/j.ejso.2024.108018.","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"2174_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1001\/jama.2015.6789","volume":"314","author":"SG Dashti","year":"2015","unstructured":"Dashti SG, Chau R, Ouakrim DA, Buchanan DD, Clendenning M, Young JP, et al. Female hormonal factors and the risk of endometrial cancer in lynch syndrome. JAMA. 2015;314(1):61\u201371. https:\/\/doi.org\/10.1001\/jama.2015.6789.","journal-title":"JAMA"},{"issue":"1","key":"2174_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10571-024-01506-0","volume":"44","author":"MS de Sousa Fernandes","year":"2024","unstructured":"de Sousa Fernandes MS, Costa MR, Badicu G, Yagin FH, Santos GCJ, da Costa JM, et al. Can Environmental enrichment modulate epigenetic processes in the central nervous system under adverse environmental conditions? A Systematic Review. Cell Mol Neurobiol. 2024;44(1):69. https:\/\/doi.org\/10.1007\/s10571-024-01506-0.","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"2174_CR24","doi-asserted-by":"publisher","first-page":"6129","DOI":"10.1038\/s41598-024-56830-8","volume":"14","author":"X Dong","year":"2024","unstructured":"Dong X, Zhan Y, Li S, Yang M, Gao Y. MKRN1 regulates the expression profiles and transcription factor activity in HeLa cells inhibition suppresses cervical cancer cell progression. Sci Rep. 2024;14(1):6129. https:\/\/doi.org\/10.1038\/s41598-024-56830-8.","journal-title":"Sci Rep"},{"key":"2174_CR25","doi-asserted-by":"publisher","unstructured":"Eising, E., N, A.D., van den Maagdenberg, A.M., and Ferrari, M.D. (2013). Epigenetic mechanisms in migraine: a promising avenue? BMC Med 11, 26. https:\/\/doi.org\/10.1186\/1741-7015-11-26.","DOI":"10.1186\/1741-7015-11-26"},{"issue":"23","key":"2174_CR26","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1056\/NEJMoa2302312","volume":"388","author":"RN Eskander","year":"2023","unstructured":"Eskander RN, Sill MW, Beffa L, Moore RG, Hope JM, Musa FB, et al. Pembrolizumab plus Chemotherapy in advanced endometrial cancer. N Engl J Med. 2023;388(23):2159\u201370. https:\/\/doi.org\/10.1056\/NEJMoa2302312.","journal-title":"N Engl J Med"},{"key":"2174_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03566-1","author":"RN Eskander","year":"2025","unstructured":"Eskander RN, Sill MW, Beffa L, Moore RG, Hope JM, Musa FB, et al. Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial. Nat Med. 2025. https:\/\/doi.org\/10.1038\/s41591-025-03566-1.","journal-title":"Nat Med"},{"issue":"5","key":"2174_CR28","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/S0002-9440(10)65492-2","volume":"155","author":"M Esteller","year":"1999","unstructured":"Esteller M, Catasus L, Matias-Guiu X, Mutter GL, Prat J, Baylin SB, et al. hMLH1 Promoter hypermethylation is an early event in human endometrial tumorigenesis. Am J Pathol. 1999;155(5):1767\u201372. https:\/\/doi.org\/10.1016\/S0002-9440(10)65492-2.","journal-title":"Am J Pathol"},{"key":"2174_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cells11050909","author":"X Fang","year":"2022","unstructured":"Fang X, Ni N, Wang X, Tian Y, Ivanov I, Rijnkels M, et al. EZH2 and Endometrial Cancer Development: Insights from a Mouse Model. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11050909.","journal-title":"Cells"},{"issue":"1","key":"2174_CR30","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12885-020-06802-8","volume":"20","author":"GM Faria","year":"2020","unstructured":"Faria GM, Soares IDP, D\u2019Alincourt Salazar M, Amorim MR, Pessoa BL, da Fonseca CO, et al. Intranasal perillyl alcohol therapy improves survival of patients with recurrent glioblastoma harboring mutant variant for MTHFR rs1801133 polymorphism. BMC Cancer. 2020;20(1):294. https:\/\/doi.org\/10.1186\/s12885-020-06802-8.","journal-title":"BMC Cancer"},{"key":"2174_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217282","volume":"605","author":"NR Field","year":"2024","unstructured":"Field NR, Dickson KA, Nassif NT, Marsh DJ. SMARCA4 and SMARCA2 co-deficiency: an uncommon molecular signature defining a subset of rare, aggressive and undifferentiated malignancies associated with defective chromatin remodeling. Cancer Lett. 2024;605:217282. https:\/\/doi.org\/10.1016\/j.canlet.2024.217282.","journal-title":"Cancer Lett"},{"issue":"17","key":"2174_CR32","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1016\/j.febslet.2015.06.043","volume":"589","author":"T Fukuda","year":"2015","unstructured":"Fukuda T, Wada-Hiraike O, Oda K, Tanikawa M, Makii C, Inaba K, et al. Putative tumor suppression function of SIRT6 in endometrial cancer. FEBS Lett. 2015;589(17):2274\u201381. https:\/\/doi.org\/10.1016\/j.febslet.2015.06.043.","journal-title":"FEBS Lett"},{"issue":"3","key":"2174_CR33","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1093\/nar\/gku1354","volume":"43","author":"A Gansen","year":"2015","unstructured":"Gansen A, T\u00f3th K, Schwarz N, Langowski J. Opposing roles of H3- and H4-acetylation in the regulation of nucleosome structure\u2013\u2013a FRET study. Nucleic Acids Res. 2015;43(3):1433\u201343. https:\/\/doi.org\/10.1093\/nar\/gku1354.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2174_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.5114\/pjp.2024.139610","volume":"75","author":"Y Gao","year":"2024","unstructured":"Gao Y, Gao J. Expression and clinical significance of KDM5A, KDM5B, and FOXO1 in endometrial cancer. Pol J Pathol. 2024;75(2):83\u201396. https:\/\/doi.org\/10.5114\/pjp.2024.139610.","journal-title":"Pol J Pathol"},{"issue":"12","key":"2174_CR35","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1038\/s41418-021-00824-w","volume":"28","author":"T Gui","year":"2021","unstructured":"Gui T, Liu M, Yao B, Jiang H, Yang D, Li Q, et al. TCF3 is epigenetically silenced by EZH2 and DNMT3B and functions as a tumor suppressor in endometrial cancer. Cell Death Differ. 2021;28(12):3316\u201328. https:\/\/doi.org\/10.1038\/s41418-021-00824-w.","journal-title":"Cell Death Differ"},{"issue":"1","key":"2174_CR36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.scib.2023.11.029","volume":"69","author":"W Guo","year":"2024","unstructured":"Guo W, Wang Z, Zhang Y, Li Y, Du Q, Zhang T, et al. Mettl3-dependent m(6)A modification is essential for effector differentiation and memory formation of CD8(+) T cells. Sci Bull (Beijing). 2024;69(1):82\u201396. https:\/\/doi.org\/10.1016\/j.scib.2023.11.029.","journal-title":"Sci Bull (Beijing)"},{"key":"2174_CR37","doi-asserted-by":"publisher","first-page":"153303382098078","DOI":"10.1177\/1533033820980781","volume":"19","author":"Y Guo","year":"2020","unstructured":"Guo Y, Zhao N, Zhou J, Dong J, Wang X. Sirtuin 2 in endometrial cancer: a potential regulator for cell proliferation, apoptosis and RAS\/ERK pathway. Technol Cancer Res Treat. 2020;19:1533033820980781. https:\/\/doi.org\/10.1177\/1533033820980781.","journal-title":"Technol Cancer Res Treat"},{"key":"2174_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cells12131694","author":"S Gupta","year":"2023","unstructured":"Gupta S, Dutta S, Hui SP. Regenerative potential of injured spinal cord in the light of epigenetic regulation and modulation. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12131694.","journal-title":"Cells"},{"issue":"6","key":"2174_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70792","volume":"14","author":"ZL Hawking","year":"2025","unstructured":"Hawking ZL, Allan JM. Landscape of TET2 mutations: from hematological malignancies to solid tumors. Cancer Med. 2025;14(6):e70792. https:\/\/doi.org\/10.1002\/cam4.70792.","journal-title":"Cancer Med"},{"key":"2174_CR40","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.cell.2016.10.024","volume":"167","author":"D Hnisz","year":"2016","unstructured":"Hnisz D, Day D, Young RA. Insulated neighborhoods: structural and functional units of mammalian gene control. Cell. 2016;167:1188\u2013200. https:\/\/doi.org\/10.1016\/j.cell.2016.10.024.","journal-title":"Cell"},{"issue":"2","key":"2174_CR41","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2023.34.e18","volume":"34","author":"JH Hong","year":"2023","unstructured":"Hong JH, Cho HW, Ouh YT, Lee JK, Chun Y. Lymphocyte activation gene (LAG)-3 is a potential immunotherapeutic target for microsatellite stable, programmed death-ligand 1 (PD-L1)-positive endometrioid endometrial cancer. J Gynecol Oncol. 2023;34(2):e18. https:\/\/doi.org\/10.3802\/jgo.2023.34.e18.","journal-title":"J Gynecol Oncol"},{"issue":"3","key":"2174_CR42","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.celrep.2012.08.030","volume":"2","author":"CH Hsu","year":"2012","unstructured":"Hsu CH, Peng KL, Kang ML, Chen YR, Yang YC, Tsai CH, et al. TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases. Cell Rep. 2012;2(3):568\u201379. https:\/\/doi.org\/10.1016\/j.celrep.2012.08.030.","journal-title":"Cell Rep"},{"issue":"1","key":"2174_CR43","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1038\/s41467-025-58317-0","volume":"16","author":"Z Hu","year":"2025","unstructured":"Hu Z, Tang M, Huang Y, Cai B, Sun X, Chen G, et al. SIRT7 facilitates endometrial cancer progression by regulating PTEN stability in an estrogen-dependent manner. Nat Commun. 2025;16(1):2989. https:\/\/doi.org\/10.1038\/s41467-025-58317-0.","journal-title":"Nat Commun"},{"issue":"5","key":"2174_CR44","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/cbin.11549","volume":"45","author":"S Huang","year":"2021","unstructured":"Huang S, Li Y, Sheng G, Meng Q, Hu Q, Gao X, et al. Sirtuin 1 promotes autophagy and proliferation of endometrial cancer cells by reducing acetylation level of LC3. Cell Biol Int. 2021;45(5):1050\u20139. https:\/\/doi.org\/10.1002\/cbin.11549.","journal-title":"Cell Biol Int"},{"key":"2174_CR45","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2024.5620","author":"F Inoue","year":"2024","unstructured":"Inoue F, Sone K, Kumegawa K, Hachijo R, Suzuki E, Tanimoto S, et al. Inhibition of protein arginine methyltransferase 6 activates interferon signaling and induces the apoptosis of endometrial cancer cells via histone modification. Int J Oncol. 2024. https:\/\/doi.org\/10.3892\/ijo.2024.5620.","journal-title":"Int J Oncol"},{"key":"2174_CR46","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.bbrc.2022.02.086","volume":"601","author":"F Inoue","year":"2022","unstructured":"Inoue F, Sone K, Toyohara Y, Tanimoto S, Takahashi Y, Kusakabe M, et al. Histone arginine methyltransferase CARM1 selective inhibitor TP-064 induces apoptosis in endometrial cancer. Biochem Biophys Res Commun. 2022;601:123\u20138. https:\/\/doi.org\/10.1016\/j.bbrc.2022.02.086.","journal-title":"Biochem Biophys Res Commun"},{"key":"2174_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2019.105681","volume":"120","author":"N Jiang","year":"2020","unstructured":"Jiang N, Li QL, Pan W, Li J, Zhang MF, Cao T, et al. PRMT6 promotes endometrial cancer via AKT\/mTOR signaling and indicates poor prognosis. Int J Biochem Cell Biol. 2020;120:105681. https:\/\/doi.org\/10.1016\/j.biocel.2019.105681.","journal-title":"Int J Biochem Cell Biol"},{"key":"2174_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2025.02.014","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, Dai A, Huang Y, Li H, Cui J, Yang H, et al. Ligand-induced ubiquitination unleashes LAG3 immune checkpoint function by hindering membrane sequestration of signaling motifs. Cell. 2025. https:\/\/doi.org\/10.1016\/j.cell.2025.02.014.","journal-title":"Cell"},{"issue":"2","key":"2174_CR49","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ygyno.2004.10.039","volume":"96","author":"F Jin","year":"2005","unstructured":"Jin F, Dowdy SC, Xiong Y, Eberhardt NL, Podratz KC, Jiang SW. Up-regulation of DNA methyltransferase 3B expression in endometrial cancers. Gynecol Oncol. 2005;96(2):531\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2004.10.039.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"2174_CR50","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12964-023-01360-5","volume":"21","author":"Q Jin","year":"2023","unstructured":"Jin Q, Qu H, Quan C. New insights into the regulation of METTL3 and its role in tumors. Cell Commun Signal. 2023;21(1):334. https:\/\/doi.org\/10.1186\/s12964-023-01360-5.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"2174_CR51","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/s1535-6108(03)00165-x","volume":"4","author":"RW Johnstone","year":"2003","unstructured":"Johnstone RW, Licht JD. Histone deacetylase inhibitors in cancer therapy: is transcription the primary target? Cancer Cell. 2003;4(1):13\u20138. https:\/\/doi.org\/10.1016\/s1535-6108(03)00165-x.","journal-title":"Cancer Cell"},{"key":"2174_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021278","author":"R Joseph","year":"2024","unstructured":"Joseph R, Dasari SK, Umamaheswaran S, Mangala LS, Bayraktar E, Rodriguez-Aguayo C, et al. EphA2- and HDAC-targeted combination therapy in endometrial cancer. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25021278.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2174_CR53","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1210\/er.2012-1043","volume":"34","author":"JJ Kim","year":"2013","unstructured":"Kim JJ, Kurita T, Bulun SE. Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev. 2013;34(1):130\u201362. https:\/\/doi.org\/10.1210\/er.2012-1043.","journal-title":"Endocr Rev"},{"key":"2174_CR54","doi-asserted-by":"publisher","unstructured":"Klotz LO, Carlberg C. Nutrigenomics and redox regulation: Concepts relating to the Special Issue on nutrigenomics. J. Redox Biol. 2023;68, 102920. https:\/\/doi.org\/10.1016\/j.redox.2023.102920.","DOI":"10.1016\/j.redox.2023.102920"},{"issue":"2","key":"2174_CR55","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/pas.0000000000001375","volume":"44","author":"DL Kolin","year":"2020","unstructured":"Kolin DL, Quick CM, Dong F, Fletcher CDM, Stewart CJR, Soma A, et al. SMARCA4-deficient Uterine sarcoma and undifferentiated endometrial carcinoma are distinct clinicopathologic entities. Am J Surg Pathol. 2020;44(2):263\u201370. https:\/\/doi.org\/10.1097\/pas.0000000000001375.","journal-title":"Am J Surg Pathol"},{"key":"2174_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093177","author":"T Kov\u00e1cs","year":"2020","unstructured":"Kov\u00e1cs T, Szab\u00f3-Meleg E, \u00c1brah\u00e1m IM. Estradiol-induced epigenetically mediated mechanisms and regulation of gene expression. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21093177.","journal-title":"Int J Mol Sci"},{"key":"2174_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-014-0077-3","author":"KJ Kron","year":"2014","unstructured":"Kron KJ, Bailey SD, Lupien M. Enhancer alterations in cancer: a source for a cell identity crisis. Genome Med. 2014. https:\/\/doi.org\/10.1186\/s13073-014-0077-3.","journal-title":"Genome Med"},{"issue":"7","key":"2174_CR58","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1136\/ijgc-2021-003340","volume":"32","author":"KC Kurnit","year":"2022","unstructured":"Kurnit KC, Fellman BM, Mills GB, Bowser JL, Xie S, Broaddus RR. Adjuvant treatment in early-stage endometrial cancer: context-dependent impact of somatic CTNNB1 mutation on recurrence-free survival. Int J Gynecol Cancer. 2022;32(7):869\u201374. https:\/\/doi.org\/10.1136\/ijgc-2021-003340.","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"2174_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.102254","volume":"9","author":"N Lakhani","year":"2024","unstructured":"Lakhani N, Cosman R, Banerji U, Rasco D, Tomaszewska-Kiecana M, Garralda E, et al. A first-in-human phase I study of the PD-1 inhibitor, retifanlimab (INCMGA00012), in patients with advanced solid tumors (POD1UM-101). ESMO Open. 2024;9(4):102254. https:\/\/doi.org\/10.1016\/j.esmoop.2024.102254.","journal-title":"ESMO Open"},{"issue":"2","key":"2174_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113707","volume":"43","author":"KB Leszczynska","year":"2024","unstructured":"Leszczynska KB, Freitas-Huhtam\u00e4ki A, Jayaprakash C, Dzwigonska M, Vitorino FNL, Horth C, et al. H2A.Z histone variants facilitate HDACi-dependent removal of H3.3K27M mutant protein in pediatric high-grade glioma cells. Cell Rep. 2024;43(2):113707. https:\/\/doi.org\/10.1016\/j.celrep.2024.113707.","journal-title":"Cell Rep"},{"key":"2174_CR61","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.gene.2018.12.076","volume":"694","author":"L Li","year":"2019","unstructured":"Li L, Shou H, Wang Q, Liu S. Investigation of the potential theranostic role of KDM5B\/miR-29c signaling axis in paclitaxel resistant endometrial carcinoma. Gene. 2019;694:76\u201382. https:\/\/doi.org\/10.1016\/j.gene.2018.12.076.","journal-title":"Gene"},{"issue":"1","key":"2174_CR62","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/0113892029277397231228062412","volume":"25","author":"M Li","year":"2024","unstructured":"Li M, Deng X, Zhou D, Liu X, Dai J, Liu Q. A novel methylation-based model for prognostic prediction in lung adenocarcinoma. Curr Genomics. 2024;25(1):26\u201340. https:\/\/doi.org\/10.2174\/0113892029277397231228062412.","journal-title":"Curr Genomics"},{"issue":"10","key":"2174_CR63","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201949425","volume":"21","author":"S Li","year":"2020","unstructured":"Li S, Feng J, Wu F, Cai J, Zhang X, Wang H, et al. TET2 promotes anti-tumor immunity by governing G-MDSCs and CD8(+) T-cell numbers. EMBO Rep. 2020;21(10):e49425. https:\/\/doi.org\/10.15252\/embr.201949425.","journal-title":"EMBO Rep"},{"issue":"11","key":"2174_CR64","first-page":"5029","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, Zhou W, Li L, Li JW, Li T, Huang C, et al. Enhancing progestin therapy via HDAC inhibitors in endometrial cancer. Am J Cancer Res. 2022;12(11):5029\u201348.","journal-title":"Am J Cancer Res"},{"issue":"9","key":"2174_CR65","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.ccell.2023.07.013","volume":"41","author":"WW Liang","year":"2023","unstructured":"Liang WW, Lu RJ, Jayasinghe RG, Foltz SM, Porta-Pardo E, Geffen Y, et al. Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin. Cancer Cell. 2023;41(9):1567-1585.e1567. https:\/\/doi.org\/10.1016\/j.ccell.2023.07.013.","journal-title":"Cancer Cell"},{"issue":"1","key":"2174_CR66","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41467-022-35710-7","volume":"14","author":"W Lin","year":"2023","unstructured":"Lin W, Chen L, Zhang H, Qiu X, Huang Q, Wan F, et al. Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation. Nat Commun. 2023;14(1):265. https:\/\/doi.org\/10.1038\/s41467-022-35710-7.","journal-title":"Nat Commun"},{"issue":"11","key":"2174_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0259330","volume":"16","author":"NT Liu","year":"2021","unstructured":"Liu NT, Perng CL, Chou YC, Ko PS, Lin YJ, Lin YC, et al. Loss of ten-eleven translocation 1 (TET1) expression as a diagnostic and prognostic biomarker of endometrial carcinoma. PLoS ONE. 2021;16(11):e0259330. https:\/\/doi.org\/10.1371\/journal.pone.0259330.","journal-title":"PLoS ONE"},{"issue":"8","key":"2174_CR68","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1097\/igc.0000000000000500","volume":"25","author":"YD Liu","year":"2015","unstructured":"Liu YD, Dai M, Yang SS, Xiao M, Meng FL, Chen XW. Overexpression of lysine-specific demethylase 1 is associated with tumor progression and unfavorable prognosis in Chinese patients with endometrioid endometrial adenocarcinoma. Int J Gynecol Cancer. 2015;25(8):1453\u201360. https:\/\/doi.org\/10.1097\/igc.0000000000000500.","journal-title":"Int J Gynecol Cancer"},{"key":"2174_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2025.11.021","author":"MW Lucas","year":"2025","unstructured":"Lucas MW, Burton EM, Dimitriadis P, Huang AC, Long GV, Mitchell TC, et al. Immune signature-based uncoupling of checkpoint inhibitor efficacy and toxicity. Immunity. 2025. https:\/\/doi.org\/10.1016\/j.immuni.2025.11.021.","journal-title":"Immunity"},{"issue":"4","key":"2174_CR70","doi-asserted-by":"publisher","first-page":"601","DOI":"10.7150\/ijms.91506","volume":"21","author":"J Ma","year":"2024","unstructured":"Ma J, Liu D, Mao X, Huang L, Ren Y, Xu X, et al. Enhanced diagnostic efficiency of endometrial carcinogenesis and progression in women with abnormal uterine bleeding through peripheral blood cytokine testing: a multicenter retrospective cohort study. Int J Med Sci. 2024;21(4):601\u201311. https:\/\/doi.org\/10.7150\/ijms.91506.","journal-title":"Int J Med Sci"},{"issue":"1","key":"2174_CR71","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s42003-023-04756-8","volume":"6","author":"A Magi","year":"2023","unstructured":"Magi A, Mattei G, Mingrino A, Caprioli C, Ronchini C, Frig\u00e8 G, et al. High-resolution nanopore methylome-maps reveal random hyper-methylation at CpG-poor regions as driver of chemoresistance in leukemias. Commun Biol. 2023;6(1):382. https:\/\/doi.org\/10.1038\/s42003-023-04756-8.","journal-title":"Commun Biol"},{"key":"2174_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102552","volume":"71","author":"F Magnoni","year":"2024","unstructured":"Magnoni F, Corso G, Maisonneuve P, Bianchi B, Accardo G, Sangalli C, et al. Comparison of long-term outcome between clinically high risk lobular versus ductal breast cancer: a propensity score matched study. EClinicalMedicine. 2024;71:102552. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102552.","journal-title":"EClinicalMedicine"},{"key":"2174_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.763464","volume":"12","author":"V Mahajan","year":"2022","unstructured":"Mahajan V, Gujral P, Jain L, Ponnampalam AP. Differential expression of steroid hormone receptors and ten eleven translocation proteins in endometrial cancer cells. Front Oncol. 2022;12:763464. https:\/\/doi.org\/10.3389\/fonc.2022.763464.","journal-title":"Front Oncol"},{"issue":"5","key":"2174_CR74","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/carcin\/bgz046","volume":"40","author":"T Makabe","year":"2019","unstructured":"Makabe T, Arai E, Hirano T, Ito N, Fukamachi Y, Takahashi Y, et al. Genome-wide DNA methylation profile of early-onset endometrial cancer: its correlation with genetic aberrations and comparison with late-onset endometrial cancer. Carcinogenesis. 2019;40(5):611\u201323. https:\/\/doi.org\/10.1093\/carcin\/bgz046.","journal-title":"Carcinogenesis"},{"issue":"2","key":"2174_CR75","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s43018-024-00894-y","volume":"6","author":"A Marabelle","year":"2025","unstructured":"Marabelle A, O\u2019Malley DM, Hendifar AE, Ascierto PA, Motola-Kuba D, Penel N, et al. Pembrolizumab in microsatellite-instability-high and mismatch-repair-deficient advanced solid tumors: updated results of the KEYNOTE-158 trial. Nat Cancer. 2025;6(2):253\u20138. https:\/\/doi.org\/10.1038\/s43018-024-00894-y.","journal-title":"Nat Cancer"},{"issue":"7330","key":"2174_CR76","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature09784","volume":"469","author":"R Margueron","year":"2011","unstructured":"Margueron R, Reinberg D. The polycomb complex PRC2 and its mark in life. Nature. 2011;469(7330):343\u20139. https:\/\/doi.org\/10.1038\/nature09784.","journal-title":"Nature"},{"issue":"12","key":"2174_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083190","volume":"8","author":"KG McLure","year":"2013","unstructured":"McLure KG, Gesner EM, Tsujikawa L, Kharenko OA, Attwell S, Campeau E, et al. RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist. PLoS ONE. 2013;8(12):e83190. https:\/\/doi.org\/10.1371\/journal.pone.0083190.","journal-title":"PLoS ONE"},{"issue":"2","key":"2174_CR78","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/cjp2.194","volume":"7","author":"S Mei","year":"2021","unstructured":"Mei S, Ge S, Wang J, Li H, Jing X, Liang K, et al. PRMT5 promotes progression of endometrioid adenocarcinoma via ER\u03b1 and cell cycle signaling pathways. J Pathol Clin Res. 2021;7(2):154\u201364. https:\/\/doi.org\/10.1002\/cjp2.194.","journal-title":"J Pathol Clin Res"},{"key":"2174_CR79","doi-asserted-by":"publisher","DOI":"10.2174\/0109298665400400251003013958","author":"L Miao","year":"2025","unstructured":"Miao L, Chen B, Li L, Ma B, Yang G, Jing L. Role of TPD52 in endometrial cancer: impact on EMT and the PI3K\/AKT and ERK\/MAPK signaling. Protein Pept Lett. 2025. https:\/\/doi.org\/10.2174\/0109298665400400251003013958.","journal-title":"Protein Pept Lett"},{"issue":"23","key":"2174_CR80","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1056\/NEJMoa2216334","volume":"388","author":"MR Mirza","year":"2023","unstructured":"Mirza MR, Chase DM, Slomovitz BM, dePont Christensen R, Nov\u00e1k Z, Black D, et al. Dostarlimab for primary advanced or recurrent endometrial cancer. N Engl J Med. 2023;388(23):2145\u201358. https:\/\/doi.org\/10.1056\/NEJMoa2216334.","journal-title":"N Engl J Med"},{"issue":"7","key":"2174_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112688","volume":"42","author":"K Miyake","year":"2023","unstructured":"Miyake K, Costa Cruz PH, Nagatomo I, Kato Y, Motooka D, Satoh S, et al. A cancer-associated METTL14 mutation induces aberrant m6A modification, affecting tumor growth. Cell Rep. 2023;42(7):112688. https:\/\/doi.org\/10.1016\/j.celrep.2023.112688.","journal-title":"Cell Rep"},{"key":"2174_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14122969","author":"S Miyamoto","year":"2022","unstructured":"Miyamoto S, Tanaka T, Hirosuna K, Nishie R, Ueda S, Hashida S, et al. Validation of a patient-derived xenograft model for cervical cancer based on genomic and phenotypic characterization. Cancers. 2022. https:\/\/doi.org\/10.3390\/cancers14122969.","journal-title":"Cancers"},{"key":"2174_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063350","author":"D Montjean","year":"2022","unstructured":"Montjean D, Neyroud AS, Yefimova MG, Benkhalifa M, Cabry R, Ravel C. Impact of endocrine disruptors upon non-genetic inheritance. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23063350.","journal-title":"Int J Mol Sci"},{"issue":"7360","key":"2174_CR84","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10351","volume":"476","author":"RD Morin","year":"2011","unstructured":"Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature. 2011;476(7360):298\u2013303. https:\/\/doi.org\/10.1038\/nature10351.","journal-title":"Nature"},{"issue":"3","key":"2174_CR85","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ygyno.2019.12.023","volume":"156","author":"F Multinu","year":"2020","unstructured":"Multinu F, Chen J, Madison JD, Torres M, Casarin J, Visscher D, et al. Analysis of DNA methylation in endometrial biopsies to predict risk of endometrial cancer. Gynecol Oncol. 2020;156(3):682\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2019.12.023.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"2174_CR86","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00726-013-1485-1","volume":"46","author":"T Murray-Stewart","year":"2014","unstructured":"Murray-Stewart T, Woster PM, Casero RA Jr. The re-expression of the epigenetically silenced e-cadherin gene by a polyamine analogue lysine-specific demethylase-1 (LSD1) inhibitor in human acute myeloid leukemia cell lines. Amino Acids. 2014;46(3):585\u201394. https:\/\/doi.org\/10.1007\/s00726-013-1485-1.","journal-title":"Amino Acids"},{"issue":"2","key":"2174_CR87","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.celrep.2014.06.016","volume":"8","author":"S Nagarajan","year":"2014","unstructured":"Nagarajan S, Hossan T, Alawi M, Najafova Z, Indenbirken D, Bedi U, et al. Bromodomain protein BRD4 is required for estrogen receptor-dependent enhancer activation and gene transcription. Cell Rep. 2014;8(2):460\u20139. https:\/\/doi.org\/10.1016\/j.celrep.2014.06.016.","journal-title":"Cell Rep"},{"key":"2174_CR88","doi-asserted-by":"publisher","DOI":"10.2174\/0115665232376803250815065514","author":"S Nagaram","year":"2025","unstructured":"Nagaram S, Sen A, Singh V, Raj Ps M, Dwivedi S, Bansal A. Role of exosomal miRNAs and Epigenetic modifications in diabetic nephropathy: insights into novel diagnostic and therapeutic strategies. Curr Gene Ther. 2025. https:\/\/doi.org\/10.2174\/0115665232376803250815065514.","journal-title":"Curr Gene Ther"},{"issue":"3","key":"2174_CR89","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41366-021-01027-6","volume":"46","author":"A Naqvi","year":"2022","unstructured":"Naqvi A, MacKintosh ML, Derbyshire AE, Tsakiroglou A-M, Walker TDJ, McVey RJ, et al. The impact of obesity and bariatric surgery on the immune microenvironment of the endometrium. Int J Obes. 2022;46(3):605\u201312. https:\/\/doi.org\/10.1038\/s41366-021-01027-6.","journal-title":"Int J Obes"},{"issue":"9","key":"2174_CR90","doi-asserted-by":"publisher","first-page":"djv178","DOI":"10.1093\/jnci\/djv178","volume":"107","author":"KT Nead","year":"2015","unstructured":"Nead KT, Sharp SJ, Thompson DJ, Painter JN, Savage DB, Semple RK, et al. Evidence of a causal association between insulinemia and endometrial cancer: a mendelian randomization analysis. J Nat Cancer Inst. 2015;107(9):djv178. https:\/\/doi.org\/10.1093\/jnci\/djv178.","journal-title":"J Nat Cancer Inst"},{"issue":"1","key":"2174_CR91","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1158\/2159-8290.Cd-15-0341","volume":"6","author":"M Neupane","year":"2016","unstructured":"Neupane M, Clark AP, Landini S, Birkbak NJ, Eklund AC, Lim E, et al. MECP2 is a frequently amplified oncogene with a novel epigenetic mechanism that mimics the role of activated RAS in malignancy. Cancer Discov. 2016;6(1):45\u201358. https:\/\/doi.org\/10.1158\/2159-8290.Cd-15-0341.","journal-title":"Cancer Discov"},{"issue":"Pt 6","key":"2174_CR92","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1242\/jeb.120071","volume":"218","author":"D Noble","year":"2015","unstructured":"Noble D. Conrad Waddington and the origin of epigenetics. J Exp Biol. 2015;218(Pt 6):816\u20138. https:\/\/doi.org\/10.1242\/jeb.120071.","journal-title":"J Exp Biol"},{"issue":"12","key":"2174_CR93","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1038\/s43018-024-00870-6","volume":"5","author":"K Nutsch","year":"2024","unstructured":"Nutsch K, Banta KL, Wu TD, Tran CW, Mittman S, Duong E, et al. TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulation. Nat Cancer. 2024;5(12):1834\u201351. https:\/\/doi.org\/10.1038\/s43018-024-00870-6.","journal-title":"Nat Cancer"},{"issue":"22","key":"2174_CR94","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.1158\/1078-0432.Ccr-22-3915","volume":"29","author":"A Oaknin","year":"2023","unstructured":"Oaknin A, Pothuri B, Gilbert L, Sabatier R, Brown J, Ghamande S, et al. Safety, efficacy, and biomarker analyses of dostarlimab in patients with endometrial cancer: interim results of the phase I GARNET study. Clin Cancer Res. 2023;29(22):4564\u201374. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-22-3915.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2174_CR95","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s12967-022-03545-x","volume":"20","author":"Y Pang","year":"2022","unstructured":"Pang Y, Bai G, Zhao J, Wei X, Li R, Li J, et al. The BRD4 inhibitor JQ1 suppresses tumor growth by reducing c-Myc expression in endometrial cancer. J Transl Med. 2022;20(1):336. https:\/\/doi.org\/10.1186\/s12967-022-03545-x.","journal-title":"J Transl Med"},{"issue":"1","key":"2174_CR96","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ygyno.2011.09.026","volume":"124","author":"YA Park","year":"2012","unstructured":"Park YA, Lee JW, Choi JJ, Jeon HK, Cho Y, Choi C, et al. The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma. Gynecol Oncol. 2012;124(1):125\u201333. https:\/\/doi.org\/10.1016\/j.ygyno.2011.09.026.","journal-title":"Gynecol Oncol"},{"key":"2174_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102665","author":"AM Paul","year":"2021","unstructured":"Paul AM, Pillai MR, Kumar R. Prognostic significance of dysregulated epigenomic and chromatin modifiers in cervical cancer. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10102665.","journal-title":"Cells"},{"key":"2174_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310463","author":"SF Pires","year":"2023","unstructured":"Pires SF, Barros JS, Costa SSD, Carmo GBD, Scliar MO, Lengert AVH, et al. Analysis of the mutational landscape of osteosarcomas identifies genes related to metastasis and prognosis and disrupted biological pathways of immune response and bone development. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241310463.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2174_CR99","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.annonc.2024.05.546","volume":"35","author":"MA Powell","year":"2024","unstructured":"Powell MA, Bj\u00f8rge L, Willmott L, Nov\u00e1k Z, Black D, Gilbert L, et al. Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel in the randomized ENGOT-EN6\/GOG-3031\/RUBY trial. Ann Oncol. 2024;35(8):728\u201338. https:\/\/doi.org\/10.1016\/j.annonc.2024.05.546.","journal-title":"Ann Oncol"},{"issue":"19","key":"2174_CR100","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.7150\/jca.46097","volume":"11","author":"X Pu","year":"2020","unstructured":"Pu X, Gu Z, Gu Z. ALKBH5 regulates IGF1R expression to promote the proliferation and tumorigenicity of endometrial cancer. J Cancer. 2020;11(19):5612\u201322. https:\/\/doi.org\/10.7150\/jca.46097.","journal-title":"J Cancer"},{"issue":"3","key":"2174_CR101","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/jjco\/hyz174","volume":"50","author":"Y Qi","year":"2020","unstructured":"Qi Y, Tan M, Zheng M, Jin S, Wang H, Liu J, et al. Estrogen\/estrogen receptor promotes the proliferation of endometrial carcinoma cells by enhancing hMOF expression. Jpn J Clin Oncol. 2020;50(3):241\u201353. https:\/\/doi.org\/10.1093\/jjco\/hyz174.","journal-title":"Jpn J Clin Oncol"},{"issue":"31","key":"2174_CR102","doi-asserted-by":"publisher","first-page":"31702","DOI":"10.18632\/oncotarget.5165","volume":"6","author":"MT Qiu","year":"2015","unstructured":"Qiu MT, Fan Q, Zhu Z, Kwan SY, Chen L, Chen JH, et al. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1. Oncotarget. 2015;6(31):31702\u201320. https:\/\/doi.org\/10.18632\/oncotarget.5165.","journal-title":"Oncotarget"},{"issue":"8","key":"2174_CR103","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.molcel.2021.02.012","volume":"81","author":"A Radzisheuskaya","year":"2021","unstructured":"Radzisheuskaya A, Shliaha PV, Grinev VV, Shlyueva D, Damhofer H, Koche R, et al. Complex-dependent histone acetyltransferase activity of KAT8 determines its role in transcription and cellular homeostasis. Mol Cell. 2021;81(8):1749-1765.e1748. https:\/\/doi.org\/10.1016\/j.molcel.2021.02.012.","journal-title":"Mol Cell"},{"key":"2174_CR104","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31961","author":"O Raglan","year":"2018","unstructured":"Raglan O, Kalliala I, Markozannes G, Cividini S, Gunter M, Nautiyal J, et al. Risk factors for endometrial cancer: an umbrella review of the literature. Int J Cancer. 2018. https:\/\/doi.org\/10.1002\/ijc.31961.","journal-title":"Int J Cancer"},{"issue":"3","key":"2174_CR105","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/his.13091","volume":"70","author":"P Ramalingam","year":"2017","unstructured":"Ramalingam P, Croce S, McCluggage WG. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology. Histopathology. 2017;70(3):359\u201366. https:\/\/doi.org\/10.1111\/his.13091.","journal-title":"Histopathology"},{"key":"2174_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2016.10.004","volume":"44","author":"J Rautela","year":"2017","unstructured":"Rautela J, Huntington ND. IL-15 signaling in NK cell cancer immunotherapy. Curr Opin Immunol. 2017;44:1\u20136. https:\/\/doi.org\/10.1016\/j.coi.2016.10.004.","journal-title":"Curr Opin Immunol"},{"key":"2174_CR107","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.3389\/fonc.2020.01152","volume":"10","author":"S Romero-Garcia","year":"2020","unstructured":"Romero-Garcia S, Prado-Garcia H, Carlos-Reyes A. Role of DNA methylation in the resistance to therapy in solid tumors. Front Oncol. 2020;10:1152. https:\/\/doi.org\/10.3389\/fonc.2020.01152.","journal-title":"Front Oncol"},{"key":"2174_CR108","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010541","author":"V Roudko","year":"2025","unstructured":"Roudko V, Del Valle DM, Radkevich E, Kelly G, Hui X, Patel M, et al. Immunological biomarkers of response and resistance to treatment with cabozantinib and nivolumab in recurrent endometrial cancer. J Immunother Cancer. 2025. https:\/\/doi.org\/10.1136\/jitc-2024-010541.","journal-title":"J Immunother Cancer"},{"issue":"4","key":"2174_CR109","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s10565-022-09751-z","volume":"39","author":"P Ruan","year":"2023","unstructured":"Ruan P, Wang S, Yang C, Huang X, Sun P, Tan A. m(6)A mRNA methylation regulates the ERK\/NF-\u03baB\/AKT signaling pathway through the PAPPA\/IGFBP4 axis to promote proliferation and tumor formation in endometrial cancer. Cell Biol Toxicol. 2023;39(4):1611\u201326. https:\/\/doi.org\/10.1007\/s10565-022-09751-z.","journal-title":"Cell Biol Toxicol"},{"issue":"2","key":"2174_CR110","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264014","volume":"17","author":"O Saglam","year":"2022","unstructured":"Saglam O, Cao B, Wang X, Toruner GA, Conejo-Garcia JR. Expression of epigenetic pathway related genes in association with PD-L1, ER\/PgR and MLH1 in endometrial carcinoma. PLoS ONE. 2022;17(2):e0264014. https:\/\/doi.org\/10.1371\/journal.pone.0264014.","journal-title":"PLoS ONE"},{"issue":"1","key":"2174_CR111","first-page":"97","volume":"61","author":"M Sasaki","year":"2001","unstructured":"Sasaki M, Dharia A, Oh BR, Tanaka Y, Fujimoto S, Dahiya R. Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer. Cancer Res. 2001;61(1):97\u2013102.","journal-title":"Cancer Res"},{"key":"2174_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2024.100524","volume":"44","author":"MB Searcy","year":"2024","unstructured":"Searcy MB, Johnson RW. Epigenetic control of the vicious cycle. J Bone Oncol. 2024;44:100524. https:\/\/doi.org\/10.1016\/j.jbo.2024.100524.","journal-title":"J Bone Oncol"},{"key":"2174_CR113","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429310703240823045808","volume":"17","author":"B Sensi","year":"2024","unstructured":"Sensi B, Angelico R, Toti L, Conte L, Coppola A, Tisone G, et al. Mechanism, potential, and concerns of immunotherapy for hepatocellular carcinoma and liver transplantation. Curr Mol Pharmacol. 2024;17:e18761429310703. https:\/\/doi.org\/10.2174\/0118761429310703240823045808.","journal-title":"Curr Mol Pharmacol"},{"key":"2174_CR114","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2025.5751","author":"X Sheng","year":"2026","unstructured":"Sheng X, Huang G, Fang M, Li K, Wu D, Zhang X, et al. Toripalimab vs dacarbazine as first-line therapy for advanced melanoma of acral subtype: the phase 3 MELATORCH randomized clinical trial. JAMA Oncol. 2026. https:\/\/doi.org\/10.1001\/jamaoncol.2025.5751.","journal-title":"JAMA Oncol"},{"issue":"1","key":"2174_CR115","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ygyno.2015.11.017","volume":"140","author":"Y Sheng","year":"2016","unstructured":"Sheng Y, Wang H, Liu D, Zhang C, Deng Y, Yang F, et al. Methylation of tumor suppressor gene CDH13 and SHP1 promoters and their epigenetic regulation by the UHRF1\/PRMT5 complex in endometrial carcinoma. Gynecol Oncol. 2016;140(1):145\u201351. https:\/\/doi.org\/10.1016\/j.ygyno.2015.11.017.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"2174_CR116","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1128\/mcb.01172-14","volume":"35","author":"A Sohni","year":"2015","unstructured":"Sohni A, Bartoccetti M, Khoueiry R, Spans L, Vande Velde J, De Troyer L, et al. Dynamic switching of active promoter and enhancer domains regulates Tet1 and Tet2 expression during cell state transitions between pluripotency and differentiation. Mol Cell Biol. 2015;35(6):1026\u201342. https:\/\/doi.org\/10.1128\/mcb.01172-14.","journal-title":"Mol Cell Biol"},{"key":"2174_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031459","author":"F Sotomayor-Lugo","year":"2024","unstructured":"Sotomayor-Lugo F, Iglesias-Barrameda N, Castillo-Aleman YM, Casado-Hernandez I, Villegas-Valverde CA, Bencomo-Hernandez AA, et al. The dynamics of histone modifications during mammalian zygotic genome activation. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25031459.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2174_CR118","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","volume":"38","author":"R Su","year":"2020","unstructured":"Su R, Dong L, Li Y, Gao M, Han L, Wunderlich M, et al. Targeting FTO suppresses cancer stem cell maintenance and immune evasion. Cancer Cell. 2020;38(1):79-96.e11. https:\/\/doi.org\/10.1016\/j.ccell.2020.04.017.","journal-title":"Cancer Cell"},{"issue":"2","key":"2174_CR119","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/bjc.2015.190","volume":"113","author":"A Talhouk","year":"2015","unstructured":"Talhouk A, McConechy MK, Leung S, Li-Chang HH, Kwon JS, Melnyk N, et al. A clinically applicable molecular-based classification for endometrial cancers. Br J Cancer. 2015;113(2):299\u2013310. https:\/\/doi.org\/10.1038\/bjc.2015.190.","journal-title":"Br J Cancer"},{"issue":"11","key":"2174_CR120","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/nsmb1338","volume":"14","author":"SD Taverna","year":"2007","unstructured":"Taverna SD, Li H, Ruthenburg AJ, Allis CD, Patel DJ. How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers. Nat Struct Mol Biol. 2007;14(11):1025\u201340. https:\/\/doi.org\/10.1038\/nsmb1338.","journal-title":"Nat Struct Mol Biol"},{"key":"2174_CR121","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1186\/1471-2407-14-752","volume":"14","author":"ER Theisen","year":"2014","unstructured":"Theisen ER, Gajiwala S, Bearss J, Sorna V, Sharma S, Janat-Amsbury M. Reversible inhibition of lysine specific demethylase 1 is a novel anti-tumor strategy for poorly differentiated endometrial carcinoma. BMC Cancer. 2014;14:752. https:\/\/doi.org\/10.1186\/1471-2407-14-752.","journal-title":"BMC Cancer"},{"issue":"2","key":"2174_CR122","first-page":"301","volume":"19","author":"T Ueda","year":"2007","unstructured":"Ueda T, Takai N, Nishida M, Nasu K, Narahara H. Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells. Int J Mol Med. 2007;19(2):301\u20138.","journal-title":"Int J Mol Med"},{"issue":"5","key":"2174_CR123","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/ng.349","volume":"41","author":"G van Haaften","year":"2009","unstructured":"van Haaften G, Dalgliesh GL, Davies H, Chen L, Bignell G, Greenman C, et al. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat Genet. 2009;41(5):521\u20133. https:\/\/doi.org\/10.1038\/ng.349.","journal-title":"Nat Genet"},{"issue":"3","key":"2174_CR124","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/cam4.1372","volume":"7","author":"A Vanderwalde","year":"2018","unstructured":"Vanderwalde A, Spetzler D, Xiao N, Gatalica Z, Marshall J. Microsatellite instability status determined by next-generation sequencing and compared with PD-L1 and tumor mutational burden in 11,348 patients. Cancer Med. 2018;7(3):746\u201356. https:\/\/doi.org\/10.1002\/cam4.1372.","journal-title":"Cancer Med"},{"key":"2174_CR125","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.canlet.2021.10.019","volume":"524","author":"PP Venkata","year":"2022","unstructured":"Venkata PP, Chen Y, Alejo S, He Y, Palacios BE, Loeffel I, et al. KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancer. Cancer Lett. 2022;524:219\u201331. https:\/\/doi.org\/10.1016\/j.canlet.2021.10.019.","journal-title":"Cancer Lett"},{"key":"2174_CR126","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.790605","volume":"10","author":"F Wan","year":"2022","unstructured":"Wan F, Chen F, Fan Y, Chen D. Clinical significance of TET2 in female cancers. Front Bioeng Biotechnol. 2022;10:790605. https:\/\/doi.org\/10.3389\/fbioe.2022.790605.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"2174_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-024-01131-7","volume":"7","author":"CW Wang","year":"2024","unstructured":"Wang CW, Muzakky H, Firdi NP, Liu TC, Lai PJ, Wang YC, et al. Deep learning to assess microsatellite instability directly from histopathological whole slide images in endometrial cancer. NPJ Digit Med. 2024;7(1):143. https:\/\/doi.org\/10.1038\/s41746-024-01131-7.","journal-title":"NPJ Digit Med"},{"issue":"1","key":"2174_CR128","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1186\/s12885-019-5802-2","volume":"19","author":"H Wang","year":"2019","unstructured":"Wang H, Wang X, Xu L, Zhang J, Cao H. Analysis of the transcriptomic features of microsatellite instability subtype colon cancer. BMC Cancer. 2019;19(1):605. https:\/\/doi.org\/10.1186\/s12885-019-5802-2.","journal-title":"BMC Cancer"},{"issue":"9","key":"2174_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107680","volume":"300","author":"R Wang","year":"2024","unstructured":"Wang R, Yu X, Ye H, Ao M, Xi M, Hou M. LncRNA FAM83H-AS1 inhibits ferroptosis of endometrial cancer by promoting DNMT1-mediated CDO1 promoter hypermethylation. J Biol Chem. 2024;300(9):107680. https:\/\/doi.org\/10.1016\/j.jbc.2024.107680.","journal-title":"J Biol Chem"},{"key":"2174_CR130","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.2147\/ott.S130022","volume":"10","author":"X Wang","year":"2017","unstructured":"Wang X, Li B. DNMT1 regulates human endometrial carcinoma cell proliferation. Onco Targets Ther. 2017;10:1865\u201373. https:\/\/doi.org\/10.2147\/ott.S130022.","journal-title":"Onco Targets Ther"},{"issue":"36","key":"2174_CR131","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303812","volume":"10","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang C, Guan X, Ma Y, Zhang S, Li F, et al. PRMT3-mediated arginine methylation of METTL14 promotes malignant progression and treatment resistance in endometrial carcinoma. Adv Sci. 2023;10(36):e2303812. https:\/\/doi.org\/10.1002\/advs.202303812.","journal-title":"Adv Sci"},{"issue":"10","key":"2174_CR132","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1038\/s41418-022-00990-5","volume":"29","author":"Y Wang","year":"2022","unstructured":"Wang Y, Yan S, Liu X, Deng F, Wang P, Yang L, et al. PRMT4 promotes ferroptosis to aggravate doxorubicin-induced cardiomyopathy via inhibition of the Nrf2\/GPX4 pathway. Cell Death Differ. 2022;29(10):1982\u201395. https:\/\/doi.org\/10.1038\/s41418-022-00990-5.","journal-title":"Cell Death Differ"},{"issue":"1","key":"2174_CR133","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s10020-024-00915-7","volume":"30","author":"X Wei","year":"2024","unstructured":"Wei X, Xiong X, Wang P, Zhang S, Peng D. SIRT1-mediated deacetylation of FOXO3 enhances mitophagy and drives hormone resistance in endometrial cancer. Mol Med. 2024;30(1):147. https:\/\/doi.org\/10.1186\/s10020-024-00915-7.","journal-title":"Mol Med"},{"issue":"9","key":"2174_CR134","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1593\/neo.08474","volume":"10","author":"W Weichert","year":"2008","unstructured":"Weichert W, Denkert C, Noske A, Darb-Esfahani S, Dietel M, Kalloger SE, et al. Expression of class I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomas. Neoplasia. 2008;10(9):1021\u20137. https:\/\/doi.org\/10.1593\/neo.08474.","journal-title":"Neoplasia"},{"issue":"1","key":"2174_CR135","doi-asserted-by":"publisher","first-page":"8984","DOI":"10.1038\/s41467-024-53313-2","volume":"15","author":"MR Wensveen","year":"2024","unstructured":"Wensveen MR, Dixit AA, van Schendel R, Kendek A, Lambooij JP, Tijsterman M, et al. Double-strand breaks in facultative heterochromatin require specific movements and chromatin changes for efficient repair. Nat Commun. 2024;15(1):8984. https:\/\/doi.org\/10.1038\/s41467-024-53313-2.","journal-title":"Nat Commun"},{"issue":"5","key":"2174_CR136","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.jaci.2018.02.042","volume":"142","author":"T Wieder","year":"2018","unstructured":"Wieder T, Eigentler T, Brenner E, R\u00f6cken M. Immune checkpoint blockade therapy. J Allergy Clin Immunol. 2018;142(5):1403\u201314. https:\/\/doi.org\/10.1016\/j.jaci.2018.02.042.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"2174_CR137","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70089","volume":"14","author":"K Wu","year":"2024","unstructured":"Wu K, Li S, Hong G, Dong H, Tang T, Liu H, et al. Targeting METTL3 as a checkpoint to enhance T cells for tumour immunotherapy. Clin Transl Med. 2024;14(11):e70089. https:\/\/doi.org\/10.1002\/ctm2.70089.","journal-title":"Clin Transl Med"},{"issue":"4","key":"2174_CR138","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3892\/ol.2021.12982","volume":"22","author":"Q Wu","year":"2021","unstructured":"Wu Q, Zhang W, Liu Y, Huang Y, Wu H, Ma C. Histone deacetylase 1 facilitates aerobic glycolysis and growth of endometrial cancer. Oncol Lett. 2021;22(4):721. https:\/\/doi.org\/10.3892\/ol.2021.12982.","journal-title":"Oncol Lett"},{"issue":"2","key":"2174_CR139","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.bbrc.2018.10.090","volume":"509","author":"Y Wu","year":"2019","unstructured":"Wu Y, Zeng K, Wang C, Wang S, Sun H, Liu W, et al. Histone acetyltransferase MOF is involved in suppression of endometrial cancer and maintenance of ER\u03b1 stability. Biochem Biophys Res Commun. 2019;509(2):541\u20138. https:\/\/doi.org\/10.1016\/j.bbrc.2018.10.090.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2174_CR140","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.ygyno.2004.11.047","volume":"96","author":"Y Xiong","year":"2005","unstructured":"Xiong Y, Dowdy SC, Xue A, Shujuan J, Eberhardt NL, Podratz KC, et al. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers. Gynecol Oncol. 2005;96(3):601\u20139. https:\/\/doi.org\/10.1016\/j.ygyno.2004.11.047.","journal-title":"Gynecol Oncol"},{"issue":"11","key":"2174_CR141","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.2174\/13816128113199990527","volume":"20","author":"S Xu","year":"2014","unstructured":"Xu S, Ren J, Chen HB, Wang Y, Liu Q, Zhang R, et al. Cytostatic and apoptotic effects of DNMT and HDAC inhibitors in endometrial cancer cells. Curr Pharm Des. 2014;20(11):1881\u20137. https:\/\/doi.org\/10.2174\/13816128113199990527.","journal-title":"Curr Pharm Des"},{"issue":"5","key":"2174_CR142","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2024.35.e64","volume":"35","author":"F Xue","year":"2024","unstructured":"Xue F, Liu L, Tao X, Zhu W. TET3-mediated DNA demethylation modification activates SHP2 expression to promote endometrial cancer progression through the EGFR\/ERK pathway. J Gynecol Oncol. 2024;35(5):e64. https:\/\/doi.org\/10.3802\/jgo.2024.35.e64.","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"2174_CR143","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/jb\/mvaa014","volume":"168","author":"C Yang","year":"2020","unstructured":"Yang C, Ota-Kurogi N, Ikeda K, Okumura T, Horie-Inoue K, Takeda S, et al. MicroRNA-191 regulates endometrial cancer cell growth via TET1-mediated epigenetic modulation of APC. J Biochem. 2020;168(1):7\u201314. https:\/\/doi.org\/10.1093\/jb\/mvaa014.","journal-title":"J Biochem"},{"key":"2174_CR144","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-212","author":"H Yang","year":"2006","unstructured":"Yang H. Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data. BMC Cancer. 2006. https:\/\/doi.org\/10.1186\/1471-2407-6-212.","journal-title":"BMC Cancer"},{"issue":"22","key":"2174_CR145","doi-asserted-by":"publisher","first-page":"5056","DOI":"10.26355\/eurrev_201711_13818","volume":"21","author":"L Yang","year":"2017","unstructured":"Yang L, Hou J, Cui XH, Suo LN, Lv YW. RG108 induces the apoptosis of endometrial cancer Ishikawa cell lines by inhibiting the expression of DNMT3B and demethylation of HMLH1. Eur Rev Med Pharmacol Sci. 2017;21(22):5056\u201364. https:\/\/doi.org\/10.26355\/eurrev_201711_13818.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"12","key":"2174_CR146","first-page":"8572","volume":"14","author":"L Yang","year":"2022","unstructured":"Yang L, Xiao J, Ma C. Circular RNA FOXO3 regulates endometrial carcinoma progression through the microRNA-29a-3p\/HDAC4 axis. Am J Transl Res. 2022;14(12):8572\u201387.","journal-title":"Am J Transl Res"},{"key":"2174_CR147","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.822745","volume":"11","author":"Q Yang","year":"2021","unstructured":"Yang Q, Chen Y, Guo R, Dai Y, Tang L, Zhao Y, et al. Interaction of ncRNA and epigenetic modifications in gastric cancer: focus on histone modification. Front Oncol. 2021;11:822745. https:\/\/doi.org\/10.3389\/fonc.2021.822745.","journal-title":"Front Oncol"},{"issue":"1","key":"2174_CR148","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000333077","volume":"58","author":"TZ Yi","year":"2012","unstructured":"Yi TZ, Li J, Han X, Guo J, Qu Q, Guo L, et al. DNMT inhibitors and HDAC inhibitors regulate E-cadherin and Bcl-2 expression in endometrial carcinoma in vitro and in vivo. Chemotherapy. 2012;58(1):19\u201329. https:\/\/doi.org\/10.1159\/000333077.","journal-title":"Chemotherapy"},{"issue":"3","key":"2174_CR149","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.26355\/eurrev_202402_35349","volume":"28","author":"AE Zacapala-G\u00f3mez","year":"2024","unstructured":"Zacapala-G\u00f3mez AE, Mendoza-Catal\u00e1n MA, Antonio-V\u00e9jar V, Jim\u00e9nez-Wences H, Ort\u00edz-Ort\u00edz J, \u00c1vila-L\u00f3pez PA, et al. TET enzymes and 5hmC epigenetic mark: new key players in carcinogenesis and progression in gynecological cancers. Eur Rev Med Pharmacol Sci. 2024;28(3):1123\u201334. https:\/\/doi.org\/10.26355\/eurrev_202402_35349.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2174_CR150","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2024.5633","author":"B Zeng","year":"2024","unstructured":"Zeng B, Wan R, Chang K, Li J, Zhang X, Shi G, et al. Lysine methyltransferase\u00a05C increases the proliferation and metastatic abilities of clear cell renal cell carcinoma via aerobic glycolysis. Int J Oncol. 2024. https:\/\/doi.org\/10.3892\/ijo.2024.5633.","journal-title":"Int J Oncol"},{"issue":"3","key":"2174_CR151","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202255762","volume":"24","author":"ZC Zeng","year":"2023","unstructured":"Zeng ZC, Pan Q, Sun YM, Huang HJ, Chen XT, Chen TQ, et al. METTL3 protects METTL14 from STUB1-mediated degradation to maintain m(6) A homeostasis. EMBO Rep. 2023;24(3):e55762. https:\/\/doi.org\/10.15252\/embr.202255762.","journal-title":"EMBO Rep"},{"issue":"1","key":"2174_CR152","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40364-023-00479-4","volume":"11","author":"L Zhan","year":"2023","unstructured":"Zhan L, Zhang J, Zhang JH, Liu XJ, Guo B, Chen JH, et al. METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer. Biomark Res. 2023;11(1):43. https:\/\/doi.org\/10.1186\/s40364-023-00479-4.","journal-title":"Biomark Res"},{"key":"2174_CR153","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.856707","volume":"12","author":"J Zhang","year":"2022","unstructured":"Zhang J, Kuang L, Li Y, Wang Q, Xu H, Liu J, et al. Metformin regulates TET2 expression to inhibit endometrial carcinoma proliferation: a new mechanism. Front Oncol. 2022;12:856707. https:\/\/doi.org\/10.3389\/fonc.2022.856707.","journal-title":"Front Oncol"},{"issue":"6","key":"2174_CR154","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1039\/d1mo00287b","volume":"18","author":"M Zhang","year":"2022","unstructured":"Zhang M, Liu Y, Hou S, Wang Y, Wang C, Yin Y, et al. KDM4B, a potential prognostic biomarker revealed by large-scale public databases and clinical samples in uterine corpus endometrial carcinoma. Molecular Omics. 2022;18(6):506\u201319. https:\/\/doi.org\/10.1039\/d1mo00287b.","journal-title":"Molecular Omics"},{"issue":"7","key":"2174_CR155","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.chembiol.2022.05.008","volume":"29","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Andrade R, Hanna AA, Pflum MKH. Evidence that HDAC7 acts as an epigenetic \u201creader\u201d of AR acetylation through NCoR-HDAC3 dissociation. Cell Chem Biol. 2022;29(7):1162\u201373. https:\/\/doi.org\/10.1016\/j.chembiol.2022.05.008.","journal-title":"Cell Chem Biol"},{"issue":"1","key":"2174_CR156","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13046-024-03114-8","volume":"43","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Yang Y, Qi X, Cui P, Kang Y, Liu H, et al. SLC14A1 and TGF-\u03b2 signaling: a feedback loop driving EMT and colorectal cancer metachronous liver metastasis. J Exp Clin Cancer Res. 2024;43(1):208. https:\/\/doi.org\/10.1186\/s13046-024-03114-8.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2174_CR157","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.canlet.2011.12.033","volume":"319","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Zhou D, Lai Y, Liu Y, Tao X, Wang Q, et al. Estrogen induces endometrial cancer cell proliferation and invasion by regulating the fat mass and obesity-associated gene via PI3K\/AKT and MAPK signaling pathways. Cancer Lett. 2012;319(1):89\u201397. https:\/\/doi.org\/10.1016\/j.canlet.2011.12.033.","journal-title":"Cancer Lett"},{"issue":"3","key":"2174_CR158","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00404-021-06216-2","volume":"305","author":"N Zhao","year":"2022","unstructured":"Zhao N, Guo Y, Liu P, Chen Y, Wang Y. Sirtuin 2 promotes cell stemness and MEK\/ERK signaling pathway while reduces chemosensitivity in endometrial cancer. Arch Gynecol Obstet. 2022;305(3):693\u2013701. https:\/\/doi.org\/10.1007\/s00404-021-06216-2.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"2174_CR159","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1038\/s41598-020-60271-4","volume":"10","author":"Y Zheng","year":"2020","unstructured":"Zheng Y, Yang X, Wang C, Zhang S, Wang Z, Li M, et al. HDAC6, modulated by miR-206, promotes endometrial cancer progression through the PTEN\/AKT\/mTOR pathway. Sci Rep. 2020;10(1):3576. https:\/\/doi.org\/10.1038\/s41598-020-60271-4.","journal-title":"Sci Rep"},{"issue":"5","key":"2174_CR160","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.7150\/ijbs.90459","volume":"20","author":"L Zhou","year":"2024","unstructured":"Zhou L, Zhong Y, Wang F, Guo Y, Mao R, Xie H, et al. WTAP Mediated N6-methyladenosine RNA Modification of ELF3 drives cellular senescence by upregulating IRF8. Int J Biol Sci. 2024;20(5):1763\u201377. https:\/\/doi.org\/10.7150\/ijbs.90459.","journal-title":"Int J Biol Sci"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-026-02174-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02174-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02174-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:02:05Z","timestamp":1792425725000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-026-02174-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":160,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2174"],"URL":"https:\/\/doi.org\/10.1186\/s13148-026-02174-1","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declare that no Generative AI was used in the creation of this manuscript.","order":3,"name":"Ethics","label":"Generative AI statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"187"}}